The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical trial.

At The Iskandar Complex Hernia Center, where innovation and surgical excellence go hand-in-hand, a groundbreaking study out ...

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of ...

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.

A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...

I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

Patients on Itovebi plus Ibrance and fulvestrant had improved progression-free and overall survival compared to Ibrance-fulvestrant alone.

Vepdegestrant is an oral proteolysis-targeting chimera (PROTAC) estrogen receptor (ER) degrader that directly harnesses the ubiquitin–proteasome system. In this phase 3, open-label, randomized ...

Does stereotactic ablative body radiotherapy (SABR) to oligoprogressive metastases delay a change in systemic therapy in patients with estrogen receptor–positive, human epidermal growth factor ...